date:Oct 08, 2012
ini et al to share key additional information.
Such shortcomings mean that EFSA is presently unable to regard the authors conclusions as scientifically sound. The numerous issues relating to the design and methodology of the study as described in the paper mean that no conclusions can be made about the occurrence of tumours in the rats tested.
Therefore, based on the information published by the authors, EFSA does not see a need to re-examine its previous safety evaluation of maize NK603 nor t